http://rdf.ncbi.nlm.nih.gov/pubchem/patent/MX-2016008214-A
Outgoing Links
| Predicate | Object |
|---|---|
| assignee | http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_10e4b1416c6e66e0ade5429212414964 |
| classificationCPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-4704 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P25-28 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K45-06 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-277 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P43-00 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K9-0053 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P25-00 |
| classificationIPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07C255-44 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-4704 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-277 |
| filingDate | 2014-12-23-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| inventor | http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_4f16b6582a60f5ddec44b936c36dfa23 |
| publicationDate | 2016-10-14-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationNumber | MX-2016008214-A |
| titleOfInvention | TREATMENT OF MULTIPLE SCLEROSIS WITH A COMBINATION OF LAQUINIMOD AND TERIFLUNOMIDE. |
| abstract | The present invention provides a method of treatment to a subject suffering from multiple sclerosis (MS) or presenting a clinically isolated syndrome (CIS), which comprises administering laquinimod to the subject as part of a combination therapy or to be used directly in combination with a higher than the minimum effective dose of teriflunomide. The present invention also provides a package and a pharmaceutical composition comprising laquinimod and higher than the minimum effective dose of teriflunomide for treating a subject afflicted with MS or presenting a CIS. The present invention also provides laquinimod for use as part of a combination therapy or to be used directly in combination with a higher than the minimum effective dose of teriflunomide in the treatment of a subject suffering from MS or presenting with a CIS. The present invention further provides the use of laquinimod and higher than the minimum effective dose of teriflunomide in the preparation of a combination for the treatment of a subject suffering from MS or presenting a CIS. |
| priorityDate | 2013-12-23-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| type | http://data.epo.org/linked-data/def/patent/Publication |
Incoming Links
Total number of triples: 23.